Advisors Management Group Inc. ADV Lowers Position in HCP, Inc. (NYSE:HCP)

Advisors Management Group Inc. ADV decreased its position in shares of HCP, Inc. (NYSE:HCP) by 0.7% during the second quarter, according to its most recent filing with the SEC. The firm owned 96,470 shares of the real estate investment trust’s stock after selling 682 shares during the period. Advisors Management Group Inc. ADV’s holdings in HCP were worth $3,085,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of HCP. Prudential Financial Inc. boosted its stake in HCP by 0.6% during the 2nd quarter. Prudential Financial Inc. now owns 438,354 shares of the real estate investment trust’s stock valued at $14,019,000 after purchasing an additional 2,428 shares during the last quarter. Cambridge Trust Co. boosted its stake in HCP by 1.3% during the 2nd quarter. Cambridge Trust Co. now owns 279,568 shares of the real estate investment trust’s stock valued at $8,941,000 after purchasing an additional 3,678 shares during the last quarter. Commonwealth Bank of Australia boosted its stake in HCP by 2,313.5% during the 2nd quarter. Commonwealth Bank of Australia now owns 1,570,166 shares of the real estate investment trust’s stock valued at $50,205,000 after purchasing an additional 1,505,109 shares during the last quarter. NEXT Financial Group Inc boosted its stake in HCP by 181.3% during the 2nd quarter. NEXT Financial Group Inc now owns 1,125 shares of the real estate investment trust’s stock valued at $36,000 after purchasing an additional 725 shares during the last quarter. Finally, Comerica Bank lifted its holdings in shares of HCP by 4.8% during the 2nd quarter. Comerica Bank now owns 200,941 shares of the real estate investment trust’s stock valued at $6,541,000 after buying an additional 9,116 shares during the period. Hedge funds and other institutional investors own 95.43% of the company’s stock.

HCP has been the topic of several research analyst reports. Argus raised HCP from a “hold” rating to a “buy” rating in a report on Tuesday, September 10th. Morgan Stanley increased their price target on HCP from $32.00 to $35.00 and gave the company an “equal weight” rating in a report on Tuesday, September 17th. ValuEngine cut HCP from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. KeyCorp raised their target price on HCP from $34.00 to $37.00 and gave the stock an “overweight” rating in a report on Wednesday, October 2nd. Finally, Stifel Nicolaus raised their target price on HCP from $34.00 to $37.00 and gave the stock a “buy” rating in a report on Tuesday, September 3rd. They noted that the move was a valuation call. Three research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $35.78.

In other news, COO Thomas Klaritch sold 35,014 shares of HCP stock in a transaction that occurred on Wednesday, September 4th. The shares were sold at an average price of $36.02, for a total transaction of $1,261,204.28. Following the completion of the sale, the chief operating officer now owns 230,529 shares of the company’s stock, valued at $8,303,654.58. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.13% of the company’s stock.

HCP traded down $0.20 on Friday, hitting $36.35. The company had a trading volume of 1,729,874 shares, compared to its average volume of 3,199,470. The company has a market cap of $17.85 billion, a PE ratio of 19.97, a PEG ratio of 6.78 and a beta of 0.23. HCP, Inc. has a 12-month low of $24.47 and a 12-month high of $36.80. The company has a quick ratio of 0.90, a current ratio of 0.90 and a debt-to-equity ratio of 0.95. The business’s fifty day simple moving average is $35.21 and its 200 day simple moving average is $32.63.

HCP (NYSE:HCP) last announced its quarterly earnings data on Wednesday, July 31st. The real estate investment trust reported ($0.03) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.43 by ($0.46). The firm had revenue of $489.15 million during the quarter, compared to the consensus estimate of $444.67 million. HCP had a return on equity of 15.54% and a net margin of 53.57%. The firm’s revenue for the quarter was up 4.5% on a year-over-year basis. During the same period in the previous year, the business earned $0.45 EPS. On average, analysts anticipate that HCP, Inc. will post 1.75 earnings per share for the current fiscal year.

HCP Profile

HCP, Inc is a fully integrated real estate investment trust (REIT) that invests in real estate serving the healthcare industry in the United States. HCP owns a large-scale portfolio primarily diversified across life science, medical office and senior housing. Recognized as a global leader in sustainability, HCP has been a publicly-traded company since 1985 and was the first healthcare REIT selected to the S&P 500 index.

See Also: What is a front-end load?

Institutional Ownership by Quarter for HCP (NYSE:HCP)

Receive News & Ratings for HCP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP and related companies with MarketBeat.com's FREE daily email newsletter.